ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "ACPA"

  • Abstract Number: 2019 • 2014 ACR/ARHP Annual Meeting

    Antibodies to Citrullinated Clusterin, Filaggrin, Vimentin, and Fibrinogen Are Associated with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis

    Jan M. Hughes-Austin1, Ryan W. Gan2, Kevin D. Deane3, Peter K. Gregersen4, Michael H. Weisman5, Joachim H. Ix6, Jeremy Sokolove7, William H. Robinson8, V. Michael Holers9 and Jill M. Norris2, 1Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, 2Epidemiology, Colorado School of Public Health, Aurora, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 4The Feinstein Institute for Medical Research, Manhasset, NY, 5Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 6University of California, San Diego, La Jolla, CA, 7VA Palo Alto Healthcare System and Stanford University, Palo Alto, CA, 8VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 9Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose Hypertension is common in rheumatoid arthritis (RA), but it is unclear whether this prevalence is due to RA-related medications or to the disease process…
  • Abstract Number: 448 • 2014 ACR/ARHP Annual Meeting

    Citrulline-Specific Autoimmunity Resides in Quiescent Circulating Memory B Cells in Rheumatoid Arthritis

    Adam Pelzek, Caroline Grönwall, Jeffrey D. Greenberg and Gregg J. Silverman, Medicine, New York University School of Medicine, New York, NY

    Background/Purpose . The detection of anti-citrullinated protein antibodies (ACPA) aids RA diagnosis, while B cell depletion by anti-CD20 can provide clinical benefits. We therefore undertook…
  • Abstract Number: 1740 • 2014 ACR/ARHP Annual Meeting

    Predicting the Evolution of Inflammatory Arthritis in ACPA-Positive Individuals: Can T-Cell Subsets Model Help?

    Laura Hunt1, Agata Burska2, Elizabeth M.A. Hensor1, Jackie L. Nam1, Frederique Ponchel1 and Paul Emery1, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds., Leeds, United Kingdom

    Background/Purpose: ACPA+ individuals with non-specific musculoskeletal symptoms are at high risk of developing rheumatoid arthritis (RA). We previously demonstrated dys-regulation of T-cell subsets with loss…
  • Abstract Number: 447 • 2014 ACR/ARHP Annual Meeting

    Rheumatoid Factor Isotypes in Relation to Antibodies Against Citrullinated Peptides in Individuals before Onset of Rheumatoid Arthritis

    Mikael Brink1, Monika Hansson2, Linda Mathsson-Alm3, Johan Rönnelid3, Lars Klareskog2 and Solbritt Rantapää-Dahlqvist4, 1Public Health & Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 2Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden, 3Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 4Public Health & Clinical Medicine/Rheumatology, Institution of Public health and clinical medicine/ Rheumatology, University of Umeå, Rheumatology, Sweden, Umeå, Sweden

    Background/Purpose The presence of rheumatoid factor (RF) and antibodies against citrullinated peptides (ACPA) has been shown to precede the development of rheumatoid arthritis (RA) by…
  • Abstract Number: 1738 • 2014 ACR/ARHP Annual Meeting

    Prominent Role of CCR6+ T Helper Cells in the Pathogenesis of ACPA+ Patients with Early RA

    Sandra M.J. Paulissen1, Jan Piet van Hamburg2, Nadine Davelaar2, Heleen Vroman3, Johanna MW Hazes4, P.H.P. de Jong5 and Erik Lubberts2, 1Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, 2Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 3Rheumatology and Pulmonary Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 4Rheumatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands, 5Department of Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands

    Background/Purpose: Presence of serum anti-citrullinated protein antibodies (ACPAs) in patients with rheumatoid arthritis (RA) predicts worse disease course and a more erosive disease. In the…
  • Abstract Number: 453 • 2014 ACR/ARHP Annual Meeting

    In a Periodontal Disease Cohort without RA, Indeterminate or Low-Positive Anti-CCP-2 Antibodies Are Associated with Multiple Distinct ACPA

    Jerry A. Molitor1, Bryan S. Michalowicz2, Ryan T. Demmer3, Jane H. Buckner4, Mark H. Wener5 and William H. Robinson6, 1Rheumatology, University of Minnesota, Minneapolis, MN, 2Department of Developmental and Surgical Sciences, University of Minnesota School of Dentistry, Minneapolis, MN, 3Epidemiology, Columbia Univ. Mailman School of Public Health, New York, NY, 4Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Rheumatology & Lab Med, University of Washington, Seattle, WA, 6Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA

    Background/Purpose: Periodontal disease (PD) and RA share the risk factors HLA DR B1 shared epitope (SE) and tobacco exposure (TE). PD may represent a risk…
  • Abstract Number: 1465 • 2014 ACR/ARHP Annual Meeting

    Follicular Helper T Cells Control Autoimmunity through IL-21/IL-21 Receptor Interaction in RA Patients

    Shikha Singla1, Minzi Chen2, Jerry Pounds Jr.2, Omar Khan2, Jerald M. Zakem2, Kismet Collins2, Tamika Webb-Detiege2, William E. Davis2, Robert Quinet2 and Xin Zhang3, 1Rheumatology, Ochner Medical Center, New Orleans, LA, 2Rheumatology, Ochsner Medical Center, New Orleans, LA, 3Institute of Translational Research, Ochsner Medical Center, New Orleans, LA

    Background/Purpose Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the synovium, causing progressive joint destruction and reduction in quality of life…
  • Abstract Number: 423 • 2014 ACR/ARHP Annual Meeting

    Circulating Anti-Citrullinated Peptide Antibodies and Cytokines As Biomarkers of Response to Disease-Modifying Antirheumatic Drugs Therapy in Early Rheumatoid Arthritis

    Mahmood MTM Ally1, Pieter Meyer2, Bridget Hodkinson3, Eustasius Musenge4, Gregory Tintinger2, Mohammed Tikly5 and Ronald Anderson1, 1University of Pretoria, Pretoria, South Africa, 2university of pretoria, pretoria, South Africa, 3Rheumatology, University of the Witwatersrand, Johannesburg, South Africa, 4University of Witwatersrand, Johannesburg, South Africa, 5Rheumatology Wits University, C H Baragwanath Hospital, Johannesburg, South Africa

    Background/Purpose Serial measurement of circulating anti-citrullinated peptide antibodies (ACPA) and cytokines is of potential importance in the management of patients with rheumatoid arthritis (RA). However,…
  • Abstract Number: 1476 • 2014 ACR/ARHP Annual Meeting

    A Dose Response Relationship Between Shared Epitope and ACPA Level: But Not All SE Alleles Are Created Equal

    Jeremy Sokolove1, Lauren J. Lahey1, Catriona Wagner2, Irene Smolik3, David B. Robinson4, Elizabeth D. Ferucci5, Marianna Newkirk6, Marvin Fritzler7, William H. Robinson8 and Hani El-Gabalawy9, 1VA Palo Alto Healthcare System and Stanford University, Palo Alto, CA, 2VA Palo Alto Heatlh Care System and Stanford University, Palo Alto, CA, 3Arthritis Center, University of Manitoba, Winnipeg, MB, Canada, 4Arthritis Centre, University of Manitoba, Winnipeg, MB, Canada, 5Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, AK, 6McGill University, Montreal, QC, Canada, 7Medicine, University of Calgary, Calgary, AB, Canada, 8VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 9University of Manitoba, Winnipeg, MB, Canada

    Background/Purpose:  Indigenous North American populations have high prevalence of seropositive RA.  The Cree/Ojibway population in Central Canada and the Alaska Native population have a high prevalence…
  • Abstract Number: 434 • 2014 ACR/ARHP Annual Meeting

    Characterization of Lung Inflammation in the Lungs of Early Rheumatoid Arthritis

    Gudrun Reynisdottir1, Vijay Joshua2, Aase Haj Hensvold2, Lars Klareskog3 and Anca I Catrina2, 1Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet,, Stockholm, Sweden, 2Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 3Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska institutet, Stockholm, Sweden

    Background/Purpose We have previously demonstrated that lung abnormalities are present already at disease onset in ACPA positive RA patients. We aimed to further investigate lung…
  • Abstract Number: 1475 • 2014 ACR/ARHP Annual Meeting

    Porphyromonas Gingivalis and Bone Turnover Biomarkers in Rheumatoid Arthritis

    Manpreet Sethi1, Anand Dusad1, Harlan Sayles2, Geoffrey Thiele3, Jeffrey Payne4, Michael J. Duryee5, Bart Hamilton6 and Ted R. Mikuls7, 1Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 3Int Med/Sec of Rheum/Immun, Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 4College of Dentistry, University of Nebraska Medical Center, Lincoln, NE, 5Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 6University of Nebraska Medical Centre and Omaha VA Medical Center, Omaha, NE, 7Veteran Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Periodontitis (PD) associated with P. gingivalis has been implicated as a risk factor for rheumatoid arthritis (RA).  We have previously demonstrated that RA patients…
  • Abstract Number: 433 • 2014 ACR/ARHP Annual Meeting

    Bronchiectasis: A Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis

    Anne-Marie Quirke1, Elizabeth Perry2, Alison Cartwright1, Clive Kelly3, Anthony De Sozya4,5, Paul Eggleton6, David Hutchinson2 and Patrick Venables7, 1Kennedy Institute, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 2Rheumatology, Royal Cornwall Hospital, Truro, United Kingdom, 3Rheumatology, Queen Elizabeth Hospital, Gateshead, United Kingdom, 4Institute for Cellular Medicine, Newcastle University, Newcastle, United Kingdom, 5Sir William Leech Centre, The Freeman Hospital, Newcastle, United Kingdom, 6Medical School, University of Exeter, Exeter, United Kingdom, 7Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom

    Background/Purpose Anti-citrullinated peptide antibodies (ACPA) are associated with smoking in patients with rheumatoid arthritis (RA). Bronchiectasis (BR), which tends to occur in non-smokers, has been…
  • Abstract Number: 1433 • 2014 ACR/ARHP Annual Meeting

    Clinical Characterization of Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Masaomi Yamasaki, Rheumatology, Shin-Yokohama Yamasaki Clinic, Yokohama, Japan

    Background/Purpose Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a common manifestation of rheumatoid lung disease.  Subclinical RA-ILD is most commonly identified on HRCT imaging. In…
  • Abstract Number: 408 • 2014 ACR/ARHP Annual Meeting

    14-3-3η Auto-Antibody Positivity Informs Better Clinical Outcomes in RA

    D. van Schaardenburg1, Mairead Murphy2, Samina Turk3, Walter P. Maksymowych4 and Anthony Marotta5, 1Jan van Breemen Research Institute, Amsterdam, Netherlands, 2Augurex Life Sciences Corp., North Vancouver, BC, Canada, 3Reade, Amsterdam, Netherlands, 4University of Alberta, Edmonton, AB, Canada, 51423 Dempsey Road, Augurex Life Sciences Corp., North Vancouver, BC, Canada

    Background/Purpose We have previously reported pilot data that patients who are only positive for 14-3-3η auto-antibodies (AAb) and negative for the 14-3-3η protein have a…
  • Abstract Number: 1248 • 2014 ACR/ARHP Annual Meeting

    Serologic and Clinical Overlap Between Sarcoidosis and the Rheumatic Autoimmume Diseases

    Sabrina Qazi1 and Marie Claire Maroun2, 1Internal Medicine-Rheumatology, Wayne State University, Detroit, MI, 2Rheumatology, Wayne State University, Detroit, MI

    Background/Purpose Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized pathologically by noncaseating epithelioid cell granulomas, primarily affecting the lungs, the eye, the skin,…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology